News | Mammography | April 13, 2016

Fujifilm Sponsors Keynote Presentation at NCoBC 2016

Keynote delivered by Nancy M. Cappello, executive director and founder of breast density inform advocacy groups

Fujifilm, NCoBC 2016, keynote presentation, Nancy Cappello, Aspire Cristalle mammography system

April 13, 2016 — Fujifilm Medical Systems U.S.A. Inc. sponsored the keynote presentation at the National Consortium of Breast Centers (NCoBC) 2016 conference delivered by Nancy M. Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy Inc. Fujifilm also showcased its Aspire Cristalle mammography system at the conference, April 9-13 in Las Vegas.

Cappello’s keynote remarks —“Why I Talk to Strangers About My Breasts”— focused on fibroglandular breast density ramifications and legislation. The impact of dense breast tissue remained exclusively in the medical journals for more than a decade until, in 2009, through Cappello’s activism, Connecticut, her home state, became the first state to mandate the reporting of dense breast tissue to the patient through the mammography report.

Cappello then launched Are You Dense Inc. and Are You Dense Advocacy Inc., both working together as a global grassroots density education and reporting movement.

“It is my personal priority—and the mission of my organizations— to ensure that patients, policymakers and healthcare providers understand the significance of dense breast tissue and the importance of regular, reliable screening,” said Cappello. “I am very grateful to have the support of Fujifilm, a company that clearly understands how educational efforts and awareness-building can help save lives.”

Fujifilm’s Aspire Cristalle mammography system features an innovative hexagonal close pattern (HCP) detector design, engineered for higher acquisition efficiency, to enhance detail for improved low dose performance. The result is sharper images with gentler dose to the patient. Additionally, Aspire Cristalle incorporates a patient calming design and Fujifilm’s patented Comfort Paddle, which is designed to make the most physically unpleasant part of mammograms noticeably more comfortable for the patient.

For more information: www.fujifilmhealthcare.com

Related Content

Recognized as the “Pulitzer Prize of the business press,” the Jesse H. Neal Award finalists are selected for exhibiting journalistic enterprise, service to the industry and editorial craftsmanship
News | Radiology Business | February 19, 2020
February 19, 2020 — Connectiv, a division of The Software and Information Industry Association (SIIA), has announced
Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast

Mammograms of a 49-year-old woman with invasive lobular carcinoma on the right-side breast. A small mass with micro-calcifications on the right-side breast was detected correctly by AI with an abnormality score of 96%. This case was recalled by 7 out of 14 radiologists (4 breast radiologists and 3 general radiologists) initially (without AI) and all 14 radiologists recalled this case correctly with the assistance of AI.

News | Artificial Intelligence | February 11, 2020
February 11, 2020 — A new study, published in...
Sponsored Content | Videos | Artificial Intelligence | February 06, 2020
ProFound AI is an FDA-cleared artificial intelligence (AI) system for reading 3-D breast tomosynthesis images.
Feature | Breast Imaging | February 03, 2020 | By Barbara Smith
Women in the United States have a 1 in 8 (or about 13 percent) lifetime risk of being diagnosed with breast cancer du
ringing the cancer bell can do more harm than good, says an ASTRO study

Image courtesy of ASTRO

News | Radiation Oncology | January 27, 2020
January 27, 2020 — It's a scene that some cancer patients dream about: they celebrate the end of a course of radiatio
A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast

A 50-y-old postmenopausal woman with fibroadenoma (arrows) in left breast. (A) Unenhanced fat-saturated T1-weighted MRI shows extreme amount of FGT (ACR d). (B) Moderate BPE is seen on dynamic contrast-enhanced MRI at 90 s. (C) Mean ADC of breast parenchyma of contralateral breast on diffusion-weighted imaging with ADC mapping is 1.5 × 10?3 mm2/s. (D) On 18F-FDG PET/CT, lesion is not 18F-FDG-avid, and BPU of normal breast parenchyma is relatively high, with SUVmax of 3.2. Photo courtesy of K Pinker, et al., Medical University of Vienna, Vienna, Austria

News | PET-MRI | January 27, 2020
January 27, 2020 — Researchers have identified several potentially useful...
Sponsored Content | Videos | Mammography | January 24, 2020
Imaging Technology News Contributing Editor Greg Freiherr interviewed...
Virtual reality during chemotherapy has been shown to improve breast cancer patients’ quality of life during the most stressful treatments
News | Virtual and Augmented Reality | January 21, 2020
January 21, 2020 — Virtual reality during chemotherapy has been shown to improve...